ATAI Life Sciences NV Cash Flow Quality Index

Latest as of September 2023: -0.42x

ATAI Life Sciences NV cash flow quality index. ATAI Life Sciences NV (9VC) has a Cash Flow Quality Index of -0.42x as of September 2023. Operating cash flow of €-18.43 Million is below net income of €44.24 Million, suggesting accrual-heavy earnings not yet converted to cash. See ATAI Life Sciences NV (9VC) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.42x

Operating CF / Net Income

Operating Cash Flow

€-18.43 Million

EUR

Net Income

€44.24 Million

EUR

Data as of

Sep 2023

Most recent filing

ATAI Life Sciences NV Cash Flow Quality Index by Year (None–None)

ATAI Life Sciences NV cash flow quality index by year from None to None. Year-by-year earnings quality comparison for ATAI Life Sciences NV. For the full cash flow conversion analysis, see cash efficiency ratio of ATAI Life Sciences NV.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.